A 62-year-old with NYHA class II HFrEF (EF 30%), eGFR 55 mL/min/1.73 m², on maximally tolerated guideline-directed therapy (carvedilol, sacubitril/val...

Question

A 62-year-old with NYHA class II HFrEF (EF 30%), eGFR 55 mL/min/1.73 m², on maximally tolerated guideline-directed therapy (carvedilol, sacubitril/valsartan, spironolactone, loop diuretic) presents for optimization. Which addition reduces HF hospitalization and CV death independent of diabetes?

Accepted Answer

Start dapagliflozin 10 mg daily

Answer

Add digoxin 0.125 mg daily

Answer

Add isosorbide mononitrate daily

Answer

Switch sacubitril/valsartan to lisinopril

Answer

Start ranolazine

us-abim MCQ (SBA): HFrEF

A 62-year-old with NYHA class II HFrEF (EF 30%), eGFR 55 mL/min/1.73 m², on maximally tolerated guideline-directed therapy (carvedilol, sacubitril/valsartan, spironolactone, loop diuretic) presents for optimization. Which addition reduces HF hospitalization and CV death independent of diabetes?